Evidence map›Paper›PMID 23536533›Full record

ReviewOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2013

Panel 5: Microbiology and immunology panel.

Timothy F Murphy, Tasnee Chonmaitree, Stephen Barenkamp, Jennelle Kyd, Johanna Nokso-Koivisto, Janak A Patel, Terho Heikkinen, Noboru Yamanaka, Pearay Ogra, W Edward Swords and 2 more

Abstract readReview
In one paragraph

Review in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Vinpocetine SuppressesJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  2. Review
  3. Otitis media.Nature reviews. Disease primers · 2016
    Review
  4. Interaction Between Allergy and Middle Ear Infection.Current allergy and asthma reports · 2016
    Review
  5. Update on otitis media - prevention and treatment.Infection and drug resistance · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Timothy F MurphyClinical and Translational Research Center, University at Buffalo, State University of New York, Buffalo, New York 14203, USA. murphyt@buffalo.edu
Tasnee Chonmaitree
Stephen Barenkamp
Jennelle Kyd
Johanna Nokso-Koivisto
Janak A Patel
Terho Heikkinen
Noboru Yamanaka
Pearay Ogra
W Edward Swords
Tania Sih
Melinda M Pettigrew

Funding

Development of a vaccine for prevention of Haemophilus influenzae otitis mediaR01AI081887 · NIAID · SAINT LOUIS UNIVERSITY · PI BARENKAMP, STEPHEN J. · 2011 to 2014
$1.2M
Microbial diversity, otitis media, and the pneumococcal transctiptomeR21DC011667 · NIDCD · YALE UNIVERSITY · PI PETTIGREW, MELINDA MARY · 2011 to 2012
$456k
10th International Post-Symposium Research Conference on Recent Advances in OtitiR13DC011455 · NIDCD · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BAKALETZ, LAUREN O, CASSELBRANT, MARGARETHA LINNEA · 2011 to 2011
$40k
NIAID NIH HHS R01 AI081887NIDCD NIH HHS R13 DC011455NIDCD NIH HHS R21 DC011667
6 · The paper itself

Abstract

objectiveThe objective is to perform a comprehensive review of the literature from January 2007 through June 2011 on the virology, bacteriology, and immunology related to otitis media. DATA SOURCES: PubMed database of the National Library of Medicine. REVIEW

methodsThree subpanels with co-chairs comprising experts in the virology, bacteriology, and immunology of otitis media were formed. Each of the panels reviewed the literature in their respective fields and wrote draft reviews. The reviews were shared with all panel members, and a second draft was created. The entire panel met at the 10th International Symposium on Recent Advances in Otitis Media in June 2011 and discussed the review and refined the content further. A final draft was created, circulated, and approved by the panel.

conclusionExcellent progress has been made in the past 4 years in advancing an understanding of the microbiology and immunology of otitis media. Advances include laboratory-based basic studies, cell-based assays, work in animal models, and clinical studies. IMPLICATIONS FOR PRACTICE: The advances of the past 4 years formed the basis of a series of short-term and long-term research goals in an effort to guide the field. Accomplishing these goals will provide opportunities for the development of novel interventions, including new ways to better treat and prevent otitis media.

Indexed as

Evidence-Based MedicineHumansOtitis MediaResearch DesignRisk AssessmentRisk Factors

Identifiers

PMID23536533
PMCPMC4021594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.